Episode 2251: Rick Perry & W. Bryan Hubbard

Overview

Episode 2251 features former Texas Governor and Energy Secretary Rick Perry alongside W. Bryan Hubbard, Executive Director of the American Ibogaine Initiative at the REID Foundation. While ibogaine does have legitimate scientific research supporting potential therapeutic applications, this episode presents significant medical misinformation by drastically overstating its efficacy, minimizing serious safety risks, and making unsubstantiated medical claims about treating multiple conditions.

Key Issues

1. Grossly Exaggerated Efficacy Claims

Claims Made:

Rogan stated ibogaine “actually cures addiction”
Claims that it “can fully resolve physiological opioid dependence with a single administration for 80% of people the first time, and 97% with a second dose”
Perry said “You can’t argue with the data”
Rogan claimed there is “no potential whatsoever for addiction to that drug”

Reality: According to a 12-month follow-up observational study published in PubMed, only 24% of patients quit using all substances with an average drug-free period of 24 months, while an additional 33% continued using their primary substance but decreased the amount used. This is dramatically different from the 80-97% “cure rate” claimed in the episode.

A systematic literature review published in the Journal of Psychopharmacology noted that “obtaining longitudinal follow-up assessments remains a major limitation of all published studies to date” and that claims of high abstinence rates “have been made but no verification currently exists.”

As Scientific American reported in their investigation of ibogaine: “Mallek is wrong. In fact, ibogaine does not work for everybody.”

2. Minimization of Serious Safety Risks

What the Episode Downplayed: The episode failed to adequately discuss the serious cardiac risks and deaths associated with ibogaine use.

The Scientific Reality:

A 2015 study published in Molecules found that ibogaine “could induce fatal cardiac arrhythmias”
Research has documented that ibogaine has “the potential to cause a heart disorder called Torsade de Pointes, a ventricular tachycardia that can degenerate into sudden death”
A systematic review found that “fatalities have been associated with ibogaine use; concomitant opioid use and comorbidities increase the risk of life-threatening complications including sudden cardiac death”
Studies have “reported severe medical complications and deaths, which seem to be associated with neuro- and cardiotoxic effects of ibogaine”

While the Stanford Medicine study on veterans with TBI did report no serious cardiac side effects, this was under carefully controlled medical conditions with concurrent magnesium administration—a crucial detail that must be emphasized when discussing ibogaine’s safety profile.

3. Unsubstantiated Claims About Treating Multiple Diseases

Claims Made: The episode claimed ibogaine is “even used to effectively treat multiple sclerosis, Lyme disease, and Parkinson’s disease.”

Reality: The scientific literature on ibogaine focuses primarily on addiction treatment and, more recently, PTSD and traumatic brain injury. There is no substantial peer-reviewed evidence supporting the claim that ibogaine effectively treats MS, Lyme disease, or Parkinson’s disease. Making these claims to a large audience without scientific backing is dangerous medical misinformation.

4. Misrepresentation of Scientific Consensus

The Episode’s Portrayal: Perry and Hubbard presented ibogaine as a proven treatment being held back by regulatory barriers, with Perry suggesting that Trump administration appointees like RFK Jr., Jay Bhattacharya, and Mehmet Oz could “push the drug across the finish line.”

The Scientific Reality: According to researchers: “The amount of high-quality scientific evidence on the effectiveness and safety of ibogaine is still limited, and more controlled clinical trials are needed to validate its therapeutic benefits.”

Dr. Bertha Madras, a Harvard Medical School professor and member of the White House Opioid Commission, stated: “People think there is going to be a magic pill that’s going to erase addiction, and that’s just not reality” and that people “should be flocking to” high-quality treatment centers with documented data “as opposed to places that have undocumented data and anecdotal evidence.”

Luis Eduardo Sandí Esquivel, director of Costa Rica’s Institute on Alcoholism and Drug Dependence, charged that clinics offering ibogaine are “simply preying on vulnerable people” and that operators “tell addicts that ibogaine will reset the brain and will take away the addiction. And of course, people pay huge amounts of money for such a beautiful and magical proposal, but this is far from reality.”

Fact-Checks and Rebuttals

Stanford Medicine Research (January 2024)

What the Study Actually Found: Stanford Medicine researchers did find that ibogaine, when co-administered with magnesium, safely led to improvements in depression, anxiety and functioning among 30 special operations veterans with traumatic brain injuries. Benefits were sustained at 1-month follow-up.

Important Context:

This was an observational study with a small sample size (30 participants)
Participants received treatment at specialized clinics under medical supervision
Concurrent magnesium was administered to help prevent heart complications
This does not constitute FDA approval or prove efficacy for the broader addiction treatment claims made in the episode

Texas $50 Million Initiative

Episode Context: Perry discussed efforts to introduce legislation in Texas for clinical trials.

Reality Check: While Texas did allocate $50 million for ibogaine clinical research in 2025, experts estimate that Texas is “probably at least six years away from seeing any movement on FDA approval for clinical trials.” This is a research investment, not evidence of proven efficacy.

Current Regulatory Status

Ibogaine remains in Schedule I status under the Controlled Substances Act, meaning it officially has “no currently accepted medical use and a high potential for abuse.” While this classification may be debated by researchers, the episode presented this as purely political rather than acknowledging the legitimate safety concerns that inform this designation.

Real-World Harm

Vulnerable Populations at Risk

People struggling with addiction are extremely vulnerable. When high-profile figures like Joe Rogan and Rick Perry present ibogaine as a near-certain “cure” for addiction with minimal risks, desperate individuals may:

Seek underground treatment without proper medical screening or cardiac monitoring, risking sudden death
Travel to foreign clinics with varying standards of care and medical supervision
Abandon evidence-based treatments like medication-assisted treatment (MAT) with methadone or buprenorphine, which have strong safety profiles and decades of research
Spend thousands of dollars on treatments with no guarantee of effectiveness

The “Magic Cure” Narrative

The framing of ibogaine as a “magic pill” that can “reset the brain” and cure addiction undermines the complex, often long-term nature of addiction recovery. Most addiction medicine experts emphasize that successful treatment typically involves:

Comprehensive behavioral therapy
Social support systems
Addressing underlying mental health conditions
In many cases, long-term medication-assisted treatment
Lifestyle and environmental changes

Presenting any single intervention as a guaranteed cure sets up unrealistic expectations and can lead to devastating disappointment when the treatment doesn’t work as promised.

Conclusion

While ibogaine represents a legitimate area of ongoing scientific research with some promising preliminary findings—particularly the Stanford study on veterans with TBI—this episode grossly misrepresented the state of the evidence. The dramatic overstatement of efficacy (claiming 80-97% cure rates when actual long-term studies show 24% abstinence), minimization of serious cardiac risks including documented fatalities, and unsubstantiated claims about treating MS, Lyme disease, and Parkinson’s disease constitute dangerous medical misinformation.

Rick Perry, as a former governor and Energy Secretary, brings political credibility but lacks medical or scientific credentials in addiction medicine or psychedelic therapy. W. Bryan Hubbard is a lawyer, not a medical professional or researcher. Neither guest is qualified to make the sweeping medical claims presented in this episode.

The scientific consensus is clear: ibogaine may have therapeutic potential worthy of continued research under controlled conditions, but it is not the miracle cure presented in this episode. More rigorous clinical trials are needed, and the serious safety risks must be clearly communicated to anyone considering this treatment.

For individuals struggling with addiction, evidence-based treatments with proven safety and efficacy profiles—including medication-assisted treatment, cognitive behavioral therapy, and comprehensive addiction treatment programs—remain the gold standard recommended by medical professionals.

Sources

“Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study” - American Journal of Drug and Alcohol Abuse (2017)
“A systematic literature review of clinical trials and therapeutic applications of ibogaine” - Journal of Psychopharmacology (2022)
“Psychoactive drug ibogaine effectively treats traumatic brain injury in special ops military vets” - Stanford Medicine News (January 2024)
“Magnesium–ibogaine therapy in veterans with traumatic brain injuries” - Nature Medicine (2024)
“An Anti-Addiction Drug Called Ibogaine Could Be a Wonder Cure–Or an Addict Killer” - Scientific American
“Texas to invest $50 million into psychedelic drug ibogaine” - Texas Tribune (2025)
“Rick Perry touts illegal psychedelic drug to Joe Rogan” - Houston Chronicle (2025)